Classification of Uterine and Cervical Tumours: An Observational Research with a Focus on Endometrial Stromal Sarcoma

article OA: green CC0

Abstract

AbstractAim: The aim of the present study was to broadly categorize the tumours of uterus and cervix and at the sametime look into occurrence of rare lesion like endometrial stromal sarcoma.Methods: The present study was conducted in Department of Pathology, conducted from January 2023 to June2023. Total 2000 cases of hysterectomy specimens received during the same period were included in the study.Results: Total 2000 cases were studied, of which 500 (25%) specimens were neoplastic. Of them, 485 (97%)cases were benign & constituted exclusively of leiomyomas. Among 15 malignant lesions, 5 cases were ofendometrial stromal sarcoma and rest 10 cases included 06 cases of endometrial carcinoma and 04 cases ofcervical carcinoma. The age group most commonly involved by leiomyoma was 36-45 yrs (55% cases of allcases of leiomyoma); that for endometrial carcinoma was 46-55 yrs (50% cases of all cases of endometrialcarcinoma); that for cervical carcinoma was 36-45 yrs (50% cases of all cases of cervical carcinoma); and thatfor endometrial stromal sarcoma was 46-55 yrs (64% cases of all cases of endometrial stromal sarcoma). Thus,it was evident that all lesions are mostly common around perimenopausal age group.Conclusion: As expected, leiomyomas turn out to be most common neoplasms of uterus and cervix. Thoughrare, certain lesions like endometrial stromal sarcoma do come across in histopathology and such lesions beingknown for poor prognosis and recurrences are important to be correctly and timely diagnosed.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T10:28:52.845273+00:00
License: CC0 · commercial use OK